skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
04/03/2018
Application #:
15428021
Filing Dt:
02/08/2017
Publication #:
Pub Dt:
08/10/2017
Inventors:
Binghui Shen, Judith Campbell, Kenneth Karanja, Li Zheng, Hongzhi Li, David Horne, Jun Xie
Title:
DNA2 INHIBITORS FOR CANCER TREATMENT
Assignment: 1
Reel/Frame:
041566/0767Recorded: 03/14/2017Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
03/13/2017
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980
Assignment: 2
Reel/Frame:
044433/0679Recorded: 12/19/2017Pages: 14
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
05/18/2017
Exec Dt:
05/18/2017
Exec Dt:
05/24/2017
Exec Dt:
11/01/2017
Exec Dt:
05/19/2017
Assignee:
1500 E. DUARTE ROAD
DUARTE, CALIFORNIA 91010
Correspondent:
MINTZ LEVIN/SAN DIEGO OFFICE
ONE FINANCIAL CENTER
BOSTON, MA 02111
Assignment: 3
Reel/Frame:
044433/0802Recorded: 12/19/2017Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
11/27/2017
Exec Dt:
11/27/2017
Assignee:
1200 E. CALIFORNIA BLVD.
PASADENA, CALIFORNIA 91125
Correspondent:
MINTZ LEVIN/SAN DIEGO OFFICE
ONE FINANCIAL CENTER
BOSTON, MA 02111

Search Results as of: 05/14/2024 01:35 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT